Table 8

Characteristics of the malarial VL co-infected patients versus the non-malarial VL patients enrolled in the MSF’s clinical trial at Um-el-Kher and Kassab Hospitals, Sudan (1998)
Variable Cases n (%) Controls n (%) Crude Odds Ratio 95% Confidence Interval
Age 89 427
Median (years), (interquartile range) 7 (4-14) 10 (6-17)
Treatment center 89 427
Kassab Hospital 17 (19.1) 134 (31.4) 1
Um-el-Kher Hospital 72 (80.9) 293 (68.6) 1.94 1.10-3.41*
Fatal outcome 89 427
No 79 (88.8) 415 (97.2) 1
Yes 10 (11.2) 12 (2.8) 4.38 1.83-10.48*
Hb level 89 427
Median (g/dl), (interquartile range) 7.5 (6.0-9.0) 8.2 (7.0-9.4)
≥5.3 g/dl 75 (84.3) 405 (94.8) 1
<5.3 g/dl 14 (15.7) 22 (5.2) 3.44 1.68-7.02*
Nutritional status 68 299
Mean Weigh for Height (%) 78.8 80.4
Weight for Height Percent ≥70% 60 (88.2) 279 (93.3) 1
Weight for Height Percent <70% 8 (11.8) 20 (6.7) 1.86 0.78-4.42
Spleen size below the costal margin 80 389
Median (cm), (interquartile range) 6 (3-8) 7 (4-10)
<6 cm 33 (41.2) 144 (37.0) 1
≥6 cm 47 (58.8) 245 (63.0) 0.84 0.51-1.37
Duration on-going sickness 86 422
Median (days), (interquartile range) 30 (15-60) 30 (20-60)
<60 days 62 (72.1) 286 (67.8) 1
≥60 days 24 (27.9) 136 (32.2) 0.81 0.49-1.36

*P-value <0.05 based on Person Chi-square test.

van den Bogaart et al.

van den Bogaart et al. BMC Public Health 2013 13:332   doi:10.1186/1471-2458-13-332

Open Data